VISCONTI, ROBERTA
 Distribuzione geografica
Continente #
AS - Asia 1.619
NA - Nord America 1.306
EU - Europa 1.231
SA - Sud America 246
AF - Africa 50
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 4.458
Nazione #
US - Stati Uniti d'America 1.235
SG - Singapore 871
RU - Federazione Russa 592
CN - Cina 372
IT - Italia 281
BR - Brasile 189
VN - Vietnam 138
HK - Hong Kong 129
NL - Olanda 58
DE - Germania 56
CA - Canada 51
GB - Regno Unito 44
FI - Finlandia 42
UA - Ucraina 41
IE - Irlanda 39
IN - India 26
KR - Corea 24
AR - Argentina 23
CI - Costa d'Avorio 20
MX - Messico 16
PL - Polonia 16
ZA - Sudafrica 16
ES - Italia 13
FR - Francia 12
EC - Ecuador 11
AT - Austria 10
BD - Bangladesh 8
BE - Belgio 7
CO - Colombia 7
JP - Giappone 7
SE - Svezia 7
ID - Indonesia 6
VE - Venezuela 6
PH - Filippine 5
AE - Emirati Arabi Uniti 4
IQ - Iraq 4
MA - Marocco 4
PE - Perù 4
PK - Pakistan 4
JO - Giordania 3
PY - Paraguay 3
TR - Turchia 3
AU - Australia 2
AZ - Azerbaigian 2
EU - Europa 2
GR - Grecia 2
KE - Kenya 2
LT - Lituania 2
MY - Malesia 2
OM - Oman 2
SA - Arabia Saudita 2
TN - Tunisia 2
AL - Albania 1
AO - Angola 1
BF - Burkina Faso 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CL - Cile 1
CV - Capo Verde 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
IL - Israele 1
IS - Islanda 1
KG - Kirghizistan 1
LU - Lussemburgo 1
MD - Moldavia 1
MR - Mauritania 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
PA - Panama 1
PT - Portogallo 1
QA - Qatar 1
SN - Senegal 1
SR - Suriname 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
UZ - Uzbekistan 1
WS - Samoa 1
Totale 4.458
Città #
Singapore 411
Moscow 141
Ashburn 131
Hong Kong 128
Chandler 116
Beijing 96
Hefei 91
Napoli 81
Santa Clara 75
Naples 70
Los Angeles 61
Amsterdam 48
Ho Chi Minh City 46
Jacksonville 42
Millbury 37
Princeton 34
Nanjing 27
The Dalles 27
Hanoi 26
Seoul 24
Boston 21
Dong Ket 21
Buffalo 19
Munich 19
New York 18
São Paulo 18
Ottawa 17
Wilmington 17
Montreal 16
Redondo Beach 16
Seattle 14
Brooklyn 12
Mexico City 12
Ann Arbor 11
Woodbridge 11
Chicago 10
Dallas 10
Des Moines 10
Johannesburg 10
Phoenix 10
Toronto 10
Warsaw 10
Frankfurt am Main 9
Atlanta 8
Chennai 8
Nuremberg 8
Orem 8
Poplar 8
Shenyang 8
Tianjin 8
London 7
Nanchang 7
Pozzuoli 7
San Giovanni Rotondo 7
Tokyo 7
Lawrence 6
Milan 6
Da Nang 5
Denver 5
Formia 5
Goiânia 5
Guayaquil 5
Jiaxing 5
Kochi 5
Porto Alegre 5
Rio de Janeiro 5
Wroclaw 5
Belo Horizonte 4
Buenos Aires 4
Changsha 4
Curitiba 4
Falls Church 4
General Trias 4
Lappeenranta 4
Phủ Lý 4
Rome 4
Stockholm 4
Turku 4
Verona 4
Vienna 4
Washington 4
Amman 3
Angri 3
Biên Hòa 3
Brussels 3
Campos dos Goytacazes 3
Cleveland 3
Cáceres 3
Dublin 3
Falkenstein 3
Giugliano In Campania 3
Haiphong 3
Jackson 3
Lahore 3
Norwalk 3
Orlando 3
Quito 3
Redwood City 3
Salt Lake City 3
Agropoli 2
Totale 2.298
Nome #
The Fcp1-Wee1-Cdk1 axis affects spindle assembly checkpoint robustness and sensitivity to antimicrotubule cancer drugs 138
Targeted inhibition of the methyltransferase SETD8 synergizes with the Wee1 inhibitor adavosertib in restraining glioblastoma growth 129
Evidence that PP2A activity is dispensable for spindle assembly checkpoint-dependent control of Cdk1 129
CCDC6 and USP7 expression levels suggest novel treatment options in high-grade urothelial bladder cancer 127
Evaluation of MGMT Gene Methylation in Neuroendocrine Neoplasms [*Della Monica, R. e Cuomo, M. co-primi autori] 126
USP7 inhibitors, downregulating CCDC6, sensitize lung neuroendocrine cancer cells to PARP-inhibitor drugs 125
A Rare Adult Primary Intracranial Sarcoma, DICER1-Mutant Identified by Epigenomic Profiling: A Case Report [*Marinelli A., Cuomo M. co-primi autori] 124
Looking Beyond the Glioblastoma Mask: Is Genomics the Right Path? 121
Epigenetic alterations in glioblastomas: Diagnostic, prognostic and therapeutic relevance 120
TRANSCRIPTIONAL PROFILE OF KI-RAS-INDUCED TRANSFORMATION OF THYROID CELLS. 110
Wee1 rather than plk1 is inhibited by AZD1775 at therapeutically relevant concentrations 109
ATM controls proper mitotic spindle structure 108
Cell cycle checkpoint in cancer: a therapeutically targetable double-edged sword 107
Fighting tubulin-targeting anticancer drug toxicity and resistance 106
Different mutations of the RET gene cause different human tumoral diseases. 105
Host fecal DNA specific methylation signatures mark gut dysbiosis and inflammation in children affected by autism spectrum disorder 104
Ret-mediated mitogenesis requires Src kinase activity. 102
Epigenetic remodelling of Fxyd1 promoters in developing heart and brain tissues [*Cuomo, M co-corresponding] 102
Requirement for proteolysis in spindle assembly checkpoint silencing. 101
The end of mitosis from a phosphatase perspective 100
Molecular biology of the MEN2 gene 98
MGMT and Whole-Genome DNA Methylation Impacts on Diagnosis, Prognosis and Therapy of Glioblastoma Multiforme 97
Analysis of CCDC6 as a novel biomarker for the clinical use of PARP1 inhibitors in malignant pleural mesothelioma 97
Glial cell line-derived neurotrophic factor differentially stimulates ret mutants associated with the multiple endocrine neoplasia type 2 syndromes and Hirschsprung's disease 95
The platelet derived growth factor controls c-myc expression through a JNK- and AP-1-dependent signaling pathway. 91
Sustaining the Spindle Assembly Checkpoint to improve cancer therapy 91
Methylome Profiling in Fabry Disease in Clinical Practice: A Proof of Concept 91
Fcp1 phosphatase controls Greatwall kinase to promote PP2A-B55 activation and mitotic progression 89
Akt/PKB promotes survival and hormone-independent proliferation of thyroid cells in the absence of de-differentiated and transforming effects. 86
Tyrosine 1062 of RET-MEN2A mediates activation of Akt (protein kinase B) and mitogen-activated protein kinase pathways leading to PC12 cell survival 81
Retrospective analysis of coagulation factor II receptor (F2R) sequence variation and coronary heart disease in hypertensive patients. 74
INCREASED IN-VIVO PHOSPHORILATION OF RET TYROSINE 1062 IS A POTENTIAL PATHOGENETIC MECHANISM OF MULTIPLE ENDOCRINE NEOPLASIA TYPE 2B. 73
Signalling of the Ret receptor tyrosine kinase through the c-Jun N-terminal Protein Kinases (JNKs): evidence for a divergence of the ERKs and JNKs pathways induced by Ret 72
New insights on oxidative stress in cancer. 70
The RFG oligomerization domain mediates kinase activation and re-localization of the RET/PTC3 oncoprotein to the plasma membrane. 65
Fcp1-dependent dephosphorylation is requiredfor M-phase-promoting factor inactivation at mitosis exit 65
Exploiting immune-dependent effects of microtubule-targeting agents to improve efficacy and tolerability of cancer treatment 65
New therapeutic perspectives in CCDC6 deficient lung cancer cells. 61
The highly malignant phenotype of anaplastic thyroid carcinoma cell lines is recessive. 59
Cloning and molecular characterization of a novel gene strongly induced by the adenovirus E1A gene in rat thyroid cells 57
New combinatorial strategies to improve the PARP inhibitors efficacy in the urothelial bladder Cancer treatment 49
Expression of the neoplastic phenotype by human thyroid carcinoma cell lines requires NFkappaB p65 protein expression. 49
Overexpression of the HIP gene coding for a heparin/heparan sulfate-binding protein in human thyroid carcinomas. 44
Ret/ptc Oncogene Activation Is An Early Event In Thyroid Carcinogenesis 43
FBXW7 and USP7 regulate CCDC6 turnover during the cell cycle and affect cancer drugs susceptibility in NSCLC 41
The Expression of the High-mobility Group Hmgi (y) Proteins Correlates With the Malignant Phenotype of Human Thyroid Neoplasias 40
A specific pluripotency-associated eRNA controls Nanog locus by shaping the epigenetic landscape and stabilizing enhancer–promoter interaction 36
The rationale for druggability of CCDC6-tyrosine kinase fusions in lung cancer 36
Only the substitution of methionine 918 with a threonine and not with other residues activates RET transforming potential 34
DNA methylation remodeling in temozolomide resistant recurrent glioblastoma: comparing epigenetic dynamics in vitro and in vivo 33
High level expression of the HMGI (Y) gene during embryonic development. 33
Block of c-myc expression by antisense oligonucleotides inhibits proliferation of human thyroid carcinoma cell lines 31
Multiple functions of the lysine methyltransferase KMT5a in cancer: potential targets for innovative therapies (R. VISCONTI LAST AND CORRESPONDING AUTHOR) 28
Type I IFNs and regulation of TH I responses: Enigmas both resolved and emerge 25
Importance of the MKK6/p38 pathway for interleukin-12-induced STAT4 serine phosphorylation and transcriptional activity 23
Signaling by Type I and II cytokine receptors: Ten years after 22
Characterization and analysis of the proximal Janus kinase 3 promoter 22
Positive Effects of Glucocorticoids on T Cell Function by Up-Regulation of IL-7 Receptor α 20
STAT4 serine phosphorylation is critical for IL-12-induced IFN-γ production but not for cell proliferation 17
The docking molecule Gab2 is induced by lymphocyte activation and is involved in signaling by interleukin-2 and interleukin-15 but not other common γ chain-using cytokines 15
Jaks and Stats as therapeutic targets 15
Janus kinases and signal transducers and activators of transcription: their roles in cytokine signaling, development and immunoregulation 12
The between now and then of lung cancer chemotherapy and immunotherapy 10
Molecular aspects of primary immunodeficiencies: Lessons from cytokine and other signaling pathways 9
Inhibition of Th1 immune response by glucocorticoids: Dexamethasone selectively inhibits IL-12-induced Stat4 phosphorylation in T lymphocytes 4
Totale 4.561
Categoria #
all - tutte 14.697
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.697


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021129 0 0 0 0 0 14 8 40 23 4 12 28
2021/2022226 1 1 0 7 0 7 3 5 40 8 74 80
2022/2023312 43 30 1 24 25 30 1 27 43 52 30 6
2023/2024232 11 37 26 27 20 6 9 36 3 2 41 14
2024/20251.308 72 79 5 9 43 67 143 77 84 129 483 117
2025/20261.984 281 187 368 426 615 107 0 0 0 0 0 0
Totale 4.561